Valuation: Avinger, Inc.

Market Cap 27.07L 23.53L 21.9L 20.11L 37.98L 26Cr 38.57L 2.58Cr 1.01Cr 13Cr 1.02Cr 99.43L 43Cr P/E 2022
-0.25x
P/E 2023 -0.19x
Enterprise Value 1.28Cr 1.12Cr 1.04Cr 95.29L 1.8Cr 122.45Cr 1.83Cr 12Cr 4.8Cr 61Cr 4.82Cr 4.71Cr 204.41Cr EV / Sales 2022
1.19x
EV / Sales 2023 1.78x
Free-Float
88.44%
Yield 2022 *
-
Yield 2023 -
3 years 0.36
Extreme 0.363
14
5 years 0.36
Extreme 0.363
312
10 years 0.36
Extreme 0.363
6,18,002.47
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer - 05/08/2024
Date Insider Type Main position Quantity % Market Cap.
23/01/25 Sell

Founder

2,215 0.0669%
23/01/25 Sell

Chief Financial Officer

1,255 0.0379%
23/01/25 Sell

Chief Executive Officer

3,690 0.1115%
Change 5-day change 1-year change 3-year change Capi.($)
-20.74%-.--%-.--%-95.61% 15.15L
-0.84%+5.24%-13.34%-18.64% 1.4TCr
+4.81%-6.82%+37.66%-8.13% 389.86Cr
+1.81%+11.70%-36.87%-55.63% 127.3Cr
-4.57%-3.84%+55.74%+106.83% 116.15Cr
+1.98%+9.99%-35.09%-44.14% 118.03Cr
+1.35%+5.63%-43.85% - 95Cr
+17.03%+10.93%+29.36%+96.15% 50Cr
-1.79%+1.39%+70.25% - 33Cr
+0.36%+2.02%-59.87%+221.90% 26Cr
Average -0.06%+3.36%+0.40%+25.34% 235.85Cr
Weighted average by Cap. +0.66%+2.16%-3.55%-8.31%

Financials

2022 2023
Net sales 82.73L 71.92L 66.94L 61.46L 1.16Cr 79Cr 1.18Cr 7.89Cr 3.1Cr 39Cr 3.11Cr 3.04Cr 131.84Cr 76.52L 66.52L 61.91L 56.85L 1.07Cr 73Cr 1.09Cr 7.3Cr 2.86Cr 36Cr 2.87Cr 2.81Cr 121.94Cr
Net income -1.76Cr -1.53Cr -1.43Cr -1.31Cr -2.47Cr -168.23Cr -2.51Cr -17Cr -6.6Cr -84Cr -6.62Cr -6.47Cr -280.83Cr -1.83Cr -1.59Cr -1.48Cr -1.36Cr -2.57Cr -174.88Cr -2.61Cr -17Cr -6.86Cr -87Cr -6.88Cr -6.73Cr -291.94Cr
Net Debt 17.56L 15.26L 14.21L 13.04L 24.63L 17Cr 25.02L 1.67Cr 65.73L 8.35Cr 65.95L 64.5L 28Cr 1.01Cr 87.97L 81.88L 75.18L 1.42Cr 97Cr 1.44Cr 9.65Cr 3.79Cr 48Cr 3.8Cr 3.72Cr 161.27Cr
Logo Avinger, Inc.
Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.
Employees
70
  1. Stock Market
  2. Stocks
  3. AVGR Stock